Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229225 | SCV000288205 | benign | Baller-Gerold syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001788038 | SCV002030223 | uncertain significance | Rothmund-Thomson syndrome type 2 | 2021-01-06 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Sema4, |
RCV002256067 | SCV002527848 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-20 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV001788038 | SCV004017284 | likely benign | Rothmund-Thomson syndrome type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001572798 | SCV004236568 | uncertain significance | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121935 | SCV000086140 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572798 | SCV001797726 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572798 | SCV001975572 | uncertain significance | not provided | no assertion criteria provided | clinical testing |